Publicaciones (41) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair

    Stem Cells and Development, Vol. 23, Núm. 13, pp. 1479-1490

  2. Altered atherosclerotic-related gene expression signature in circulating mononuclear leukocytes from hypercholesterolemic patients with low HDL cholesterol levels

    International Journal of Cardiology, Vol. 173, Núm. 2, pp. 337-338

  3. Arteriosclerosis in the 21st century

    Angiologia, Vol. 66, Núm. 3, pp. 109-111

  4. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury

    PLoS ONE, Vol. 9, Núm. 4

  5. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio

    PLoS ONE, Vol. 9, Núm. 4

  6. Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: Results of a prospective, multicenter, phase II clinical trial

    Haematologica, Vol. 99, Núm. 3, pp. 505-510

  7. Bilateral peripheral facial palsy secondary to Waldenström's macroglobulinemia. A case report and literature review

    Acta Haematologica Polonica, Vol. 45, Núm. 4, pp. 374-377

  8. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

    Haematologica, Vol. 99, Núm. 1, pp. 155-162

  9. Comparación de guías internacionales sobre púrpura trombocitopénica autoinmunitaria primaria

    Medicina Clinica, Vol. 143, Núm. 9, pp. 408-419

  10. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration

    Journal of Controlled Release, Vol. 173, Núm. 1, pp. 132-139

  11. Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

    Leukemia, Vol. 28, Núm. 2, pp. 391-397

  12. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

    Applied Immunohistochemistry and Molecular Morphology, Vol. 22, Núm. 10, pp. 768-773

  13. Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

    Thrombosis Research, Vol. 134, Núm. 4, pp. 774-782

  14. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

    Vascular health and risk management, Vol. 10, pp. 627-639

  15. Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction

    Biomaterials, Vol. 35, Núm. 1, pp. 143-151

  16. Evaluación del impacto de cartas de condolencia en familiares en duelo

    Medicina Paliativa, Vol. 21, Núm. 3, pp. 98-104

  17. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

    Leukemia, Vol. 28, Núm. 4, pp. 823-829

  18. GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: Do we still need alkylators?

    Blood, Vol. 124, Núm. 12, pp. 1887-1893

  19. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 Inhibition as an antimyeloma strategy

    Molecular Cancer Therapeutics, Vol. 13, Núm. 2, pp. 504-516

  20. Haemostatic activation and inflammatory response after three methods of treatment of great saphenous vein incompetence

    Phlebology, Vol. 29, Núm. 3, pp. 154-163